Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Mackall Website

Crystal L. Mackall, M.D.

Selected Publications

1)  van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM.
Enhancing immune reconstitution: from bench to bedside.
Biol. Blood Marrow Transplant. 19: S79-83, 2013.
[Journal]
2)  Zhang H, Maric I, Diprima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL.
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.
Blood. 122: 1105-13, 2013.
[Journal]
3)  Brehm C, Huenecke S, Pfirrmann V, Rossig C, Mackall CL, Bollard CM, Gottschalk S, Schlegel PG, Klingebiel T, Bader P.
Highlights of the third international conference on immunotherapy in pediatric oncology.
Pediatr Hematol Oncol. 30: 349-66, 2013.
[Journal]
4)  Lundström W, Highfill S, Walsh ST, Beq S, Morse E, Kockum I, Alfredsson L, Olsson T, Hillert J, Mackall CL.
Soluble IL7Ra potentiates IL-7 bioactivity and promotes autoimmunity.
Proc. Natl. Acad. Sci. U.S.A. 110: E1761-70, 2013.
[Journal]
5)  Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ.
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood. 121: 1165-74, 2013.
[Journal]
6)  Orentas RJ, Yang JJ, Wen X, Wei JS, Mackall CL, Khan J.
Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers.
Front Oncol. 2: 194, 2012.
[Journal]
7)  Lundström W, Fewkes NM, Mackall CL.
IL-7 in human health and disease.
Semin. Immunol. 24: 218-24, 2012.
[Journal]
8)  Orentas RJ, Lee DW, Mackall C.
Immunotherapy targets in pediatric cancer.
Front Oncol. 2: 3, 2012.
[Journal]
9)  Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL.
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.
J. Clin. Oncol. 30: 4141-7, 2012.
[Journal]
10)  Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL.
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.
Biol. Blood Marrow Transplant. 18: 698-707, 2012.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/25/2013.